Thyrotropin-Secreting Pituitary Adenoma Successfully Treated With Cabergoline

Background: Thyrotropin secreting pituitary adenomas (TSH-oma) account for less than 1% of pituitary adenomas and are a rare cause of hyperthyroidism. In this case, we describe the safe use of cabergoline with the subsequent achievement of euthyroid levels and the resolution of symptoms. Clinical Ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Saand, Aisha R, Flores, Monica, Alqaisi, Sura, Lashin, Ossama
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Thyroid
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8266158/
http://dx.doi.org/10.1210/jendso/bvab048.1977

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8266158/
http://dx.doi.org/10.1210/jendso/bvab048.1977

Ejemplares similares